Printer Friendly
The Free Library
19,595,263 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

China Bio-pharmaceutical Summit 2009 to be Organized by CBI China.


-- Shanghai Shanghai (shăng`hī`, shäng`hī`), city (1994 est. pop. 12,980,000), in, but independent of, Jiangsu prov., E China, on the Huangpu (Whangpoo) River where it flows into the Chang (Yangtze) estuary. , China, Dec. 10(th)-11(th)

SHANGHAI -- Biotechnology is an emerging industry to which many countries are attaching great importance. China is determined to grasp the great opportunities brought by the biotechnology revolution. Biotech bi·o·tech  
n. Informal
Biotechnology.


biotech
Noun

short for biotechnology

Noun 1.
 industry will become a pillar pillar, freestanding columnar supporting member. It is a general term, little used as an exact architectural definition except as applied to an upright support in the medieval styles, consisting of an assemblage of juxtaposed shafts and moldings; unlike the column,  of China's hi-tech sector, in which bio-pharmaceutical is playing a leading role.

How do pharmaceutical companies understand medicine pricing administration? How to maximize the achievement after the success of R&D? How do we select the products with high potentials while popular products are playing a bigger role? In the China Bio-pharmaceutical Summit 2009 (Dec. 10(th) -11(th), Shanghai China), the above mentioned questions will be answered thoroughly.

This event features the theme of "boosting industry integration and innovation through in-depth interpretation of policies and market landscape; focusing on industry milestones of 2009", so as to enhance the high-level exchange between bio-pharmaceutical enterprises, research institutes, contractors, relevant service providers and investment institutions, etc.

The Bacterin bac·ter·in
n.
A suspension of killed or weakened bacteria used as a vaccine.



bacterin

vaccine consisting of killed bacteria.
 Day on Dec. 11th will highlight topics on bacterin technologies, vaccine vaccine

Preparation containing either killed or weakened live microorganisms or their toxins, introduced by mouth, by injection, or by nasal spray to stimulate production of antibodies against an infectious agent.
 transportation and testing, advice on legal and investment issues, etc. This session will help the delegates better understand the vaccine market.

Confirmed attendees include (without limitation):

AstraZeneca Pharmaceutical Co., Ltd. Aisa, R&D Director

Livzon Pharmaceutical Group Inc, R&D Manager

Beijing kendlewits Pharmaceutical, Marketing Manager

Medical Information Consulting Co., Ltd., Marketing Director

Keyuan Xinhai Pharmaceutical Management Co., Ltd., Project Manager

Merck Sharp & Dohme (China) Co., Ltd., Director

Ministry of Health of the People's Republic People's Republic
n.
A political organization founded and controlled by a national Communist party.
, Director

China Bio-Technology Group Headquarters, Vice President

Otsuka (China) Investment Co., Ltd., Investment Manager

Chinese Center for Disease Control and Prevention Noun 1. Center for Disease Control and Prevention - a federal agency in the Department of Health and Human Services; located in Atlanta; investigates and diagnoses and tries to control or prevent diseases (especially new and unusual diseases)
CDC
, Director

Biomedical bi·o·med·i·cal
adj.
1. Of or relating to biomedicine.

2. Of, relating to, or involving biological, medical, and physical sciences.
 Development Co., Ltd., CRO Project Manager

Medicine & human Body Research of Zhouyi Theory, President

GlaxoSmithKline Biological Products Co., Ltd., General Manager

O

For more information, please visit: http://events.cbichina.com/con/bio09/index.html
COPYRIGHT 2009 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2009 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:9CHIN
Date:Oct 29, 2009
Words:300
Previous Article:Research and Markets: The Next Generation of Health Coaching: Multi-Platform Models for Sustained Behavior Change.
Next Article:Key Senior Appointment Strengthens TNS Payments Team.
Topics:



Related Articles
CHINA BIOLOGIC PROVIDES GUIDANCE FOR $90-100 MIL REVENUES.
Lee's Pharmaceutical Enters into Agreement with Nippon Shinyaku, a Move To Accelerate Market Diversification in China.
Lee's Pharmaceutical Enters into Agreement with Nippon Shinyaku, a Move To Accelerate Market Diversification in China.
2009.
TAITRA kicks off 2009 Taipei Pack show.
Lijun International Pharmaceutical Announcement of Profit Growth.
Julphar announces supply agreement with Hualan Biological Bacterin Co. Ltd for H1N1 vaccine.
Lee's Pharmaceutical Enters into Agreement with Nippon Shinyaku, a Move To Accelerate Market Diversification in China.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles